Ferroptosis: A potential therapeutic target in autoimmune disease (Review)

被引:10
|
作者
Shen, Liang [1 ]
Wang, Xiaohan [2 ]
Zhai, Changlin [1 ]
Chen, Yunqing [3 ,4 ]
机构
[1] Jiaxing Univ, Affiliated Hosp, Dept Cardiol, Jiaxing 314000, Zhejiang, Peoples R China
[2] Jiaxing Univ, Affiliated Hosp, Dept Gastroenterol, Jiaxing 314000, Zhejiang, Peoples R China
[3] Jiaxing Univ, Affiliated Hosp, Dept Infect Dis, Jiaxing 314000, Zhejiang, Peoples R China
[4] Jiaxing Univ, Dept Infect Dis, Affiliated Hosp, 1882 Zhonghuan South Rd, Jiaxing 314000, Zhejiang, Peoples R China
关键词
ferroptosis; autoimmune disease; immune system; therapeutic target; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DOUBLE-BLIND; PARKINSONS-DISEASE; ULCERATIVE-COLITIS; LIPID-PEROXIDATION; CELL-DEATH; VITAMIN-E; T-CELLS; SELENIUM SUPPLEMENTATION; RHEUMATOLOGY GUIDELINE;
D O I
10.3892/etm.2023.12067
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Ferroptosis is a distinct type of regulated cell death characterized by iron overload and lipid peroxidation. Ferroptosis is regulated by numerous factors and controlled by several mechanisms. This cell death type has a relationship with the immune system, which may be regulated by damage-associated molecular patterns. Ferroptosis participates in the progression of autoimmune diseases, including autoimmune hepatitis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, Parkinson's Disease, psoriasis and insulin-dependent diabetes mellitus. The present review summarizes the role of ferroptosis in autoimmune disorders and discusses ferroptosis as a potential therapeutic target for autoimmune disease.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Review article: the endocannabinoid system in liver disease, a potential therapeutic target
    Basu, P. P.
    Aloysius, M. M.
    Shah, N. J.
    Brown, R. S., Jr.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (08) : 790 - 801
  • [32] TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
    Zixin, Ye
    Lulu, Chen
    Xiangchang, Zeng
    Qing, Fang
    Binjie, Zheng
    Chunyang, Luo
    Tai, Rao
    Dongsheng, Ouyang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential
    Danhua Ruan
    Jirui Wen
    Fei Fang
    Yuqin Lei
    Zhiwei Zhao
    Yali Miao
    Cell Death Discovery, 9
  • [34] Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future
    Li, Chang
    Yin, Xunzhe
    Liu, Zuojia
    Wang, Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [35] Ferroptosis as a potential therapeutic target for age-related macular degeneration
    Liu, Dongcheng
    Liu, Ziling
    Liao, Hongxia
    Chen, Zhe-Sheng
    Qin, Bo
    DRUG DISCOVERY TODAY, 2024, 29 (04)
  • [36] Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential
    Ruan, Danhua
    Wen, Jirui
    Fang, Fei
    Lei, Yuqin
    Zhao, Zhiwei
    Miao, Yali
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [37] Ferroptosis as a Therapeutic Target in Neurodegenerative Diseases: Exploring the Mechanisms and Potential of Treating Alzheimer's Disease and Parkinson's Disease
    Zhong, Hui
    Liu, Hanxiang
    Fu, Qiang
    PROTEIN AND PEPTIDE LETTERS, 2024, 31 (10): : 759 - 772
  • [38] NF-κB as a therapeutic target in autoimmune disease
    O'Sullivan, Brendan
    Thompson, Angus
    Thomas, Ranjeny
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (02) : 111 - 122
  • [39] Metformin in SLE: metabolism as a therapeutic target in autoimmune disease
    Nikpour, Mandana
    LANCET RHEUMATOLOGY, 2020, 2 (04): : E196 - E197
  • [40] GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential
    Hamilton, John A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (04) : 457 - 465